{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:49:06Z","timestamp":1777661346818,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institutes of Environmental Health Sciences","doi-asserted-by":"crossref","award":["R01ES028668"],"award-info":[{"award-number":["R01ES028668"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000066","name":"National Institutes of Environmental Health Sciences","doi-asserted-by":"crossref","award":["P30ES006694"],"award-info":[{"award-number":["P30ES006694"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inflammatory liver diseases, including nonalcoholic steatohepatitis (NASH), alcohol-associated liver disease (ALD), hepatitis C virus (HCV), and ALD\/HCV, account for nearly 2 million deaths annually. Despite increasing evidence that liver dysfunction impacts renal physiology, there is limited supportive clinical information, due to limited diagnosis of liver disease, complexity in liver disease etiology, and inadequacy of renal function tests. Human kidney biopsies with liver and renal pathology were obtained from patients with nonalcoholic fatty liver disease (NAFLD), NASH, ALD, HCV, and ALD\/HCV (n\u2009=\u20095\u20137). Each liver disease showed renal pathology with at least 50% interstitial nephritis, 50% interstitial fibrosis, and renal dysfunction by estimated glomerular filtration rate (NAFLD 36.7\u2009\u00b1\u200921.4; NASH 32.7\u2009\u00b1\u200915.0; ALD 16.0\u2009\u00b1\u200911.0; HCV 27.6\u2009\u00b1\u200911.5; ALD\/HCV 21.0\u2009\u00b1\u200911.2\u2009ml\/min\/1.73 m2). Transcriptomic analysis identified 55 genes with expression changes in a conserved direction in response to liver disease. Considering association with immune regulation, protein levels of alpha-2-macroglobulin, clusterin, complement C1q C chain (C1QC), CD163, and joining chain of multimeric IgA and IgM (JCHAIN) were further quantified by LC-MS\/MS. C1QC demonstrated an increase in NASH, ALD, HCV, and ALD\/HCV (42.9\u2009\u00b1\u200916.6; 38.8\u2009\u00b1\u200918.4; 39.0\u2009\u00b1\u200913.5; 40.1\u2009\u00b1\u200920.1\u2009pmol\/mg protein) relative to control (19.2\u2009\u00b1\u200910.4\u2009pmol\/mg protein; p\u2009\u2264\u20090.08). Renal expression changes identified in inflammatory liver diseases with interstitial pathology suggest the pathogenesis of liver associated renal dysfunction. This unique cohort overcomes diagnostic discrepancies and sample availability to provide insight for mechanistic investigations on the impact of liver dysfunction on renal physiology.<\/jats:p>","DOI":"10.1093\/toxsci\/kfac070","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T13:50:02Z","timestamp":1657029002000},"page":"62-72","source":"Crossref","is-referenced-by-count":11,"title":["Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination"],"prefix":"10.1093","volume":"189","author":[{"given":"Kayla L","family":"Frost","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4215-9434","authenticated-orcid":false,"given":"Joseph L","family":"Jilek","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4643-3229","authenticated-orcid":false,"given":"Austin D","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Pathology, Banner University Medical Center , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shripad","family":"Sinari","sequence":"additional","affiliation":[{"name":"The University of Arizona Center for Biomedical Informatics & Biostatistics, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmira","family":"Torabzedehkorasani","sequence":"additional","affiliation":[{"name":"The University of Arizona Center for Biomedical Informatics & Biostatistics, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean D","family":"Billheimer","sequence":"additional","affiliation":[{"name":"The University of Arizona Center for Biomedical Informatics & Biostatistics, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick G","family":"Schnellmann","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-7259","authenticated-orcid":false,"given":"Nathan J","family":"Cherrington","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, College of Pharmacy, University of Arizona , Tucson, Arizona 85721, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"2022123013015230300_kfac070-B1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol"},{"key":"2022123013015230300_kfac070-B2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ackd.2015.05.003","article-title":"GFR estimating equations and liver disease","volume":"22","author":"Beben","year":"2015","journal-title":"Adv. Chronic Kidney Dis"},{"key":"2022123013015230300_kfac070-B3","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jhep.2016.06.011","article-title":"Hepatitis C virus infection and chronic kidney disease: Time for reappraisal","volume":"65","author":"Cacoub","year":"2016","journal-title":"J. Hepatol"},{"key":"2022123013015230300_kfac070-B4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"2022123013015230300_kfac070-B5","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1089\/ars.2012.4834","article-title":"Cd163 and inflammation: Biological, diagnostic, and therapeutic aspects","volume":"18","author":"Etzerodt","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"2022123013015230300_kfac070-B6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12664-018-0920-3","article-title":"Hepatitis C virus infection and chronic renal disease: A review","volume":"37","author":"Goel","year":"2018","journal-title":"Indian J. Gastroenterol"},{"key":"2022123013015230300_kfac070-B7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05750515","article-title":"The native kidney biopsy: Update and evidence for best practice","volume":"11","author":"Hogan","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"2022123013015230300_kfac070-B8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1753425909339815","article-title":"Evidence that a C1q\/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity","volume":"16","author":"Hosszu","year":"2010","journal-title":"Innate Immun"},{"key":"2022123013015230300_kfac070-B9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"2022123013015230300_kfac070-B10","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.apsb.2021.05.030","article-title":"Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity","volume":"11","author":"Jilek","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"2022123013015230300_kfac070-B11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-3083.2000.00790.x","article-title":"Role of J chain in secretory immunoglobulin formation","volume":"52","author":"Johansen","year":"2000","journal-title":"Scand. J. Immunol"},{"key":"2022123013015230300_kfac070-B12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/cts.12321","article-title":"Association of hepatitis C virus infection with proteinuria and glomerular filtration rate","volume":"8","author":"Kurbanova","year":"2015","journal-title":"Clin. Transl. Sci"},{"key":"2022123013015230300_kfac070-B13","first-page":"3","article-title":"Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins","volume":"65","author":"LaMarre","year":"1991","journal-title":"Lab. Invest"},{"key":"2022123013015230300_kfac070-B14","first-page":"434","article-title":"Hepatitis C virus and its renal manifestations: A review and update","volume":"8","author":"Latt","year":"2012","journal-title":"Gastroenterol. Hepatol"},{"key":"2022123013015230300_kfac070-B15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CN107854","article-title":"Association of C1q deposition with renal outcomes in IgA nephropathy","volume":"80","author":"Lee","year":"2013","journal-title":"Clin. Nephrol"},{"key":"2022123013015230300_kfac070-B16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4254\/wjh.v10.i10.662","article-title":"Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis","volume":"10","author":"Lin","year":"2018","journal-title":"World J. Hepatol"},{"key":"2022123013015230300_kfac070-B17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1681\/ASN.2014101000","article-title":"Current understanding of the role of complement in IgA nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J. Am. Soc. Nephrol"},{"key":"2022123013015230300_kfac070-B18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.ajkd.2008.03.009","article-title":"Association of hepatitis C virus infection with prevalence and development of kidney disease","volume":"51","author":"Moe","year":"2008","journal-title":"Am. J. Kidney Dis"},{"key":"2022123013015230300_kfac070-B19","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: Novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"},{"key":"2022123013015230300_kfac070-B20","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"2022123013015230300_kfac070-B21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40620-018-0531-1","article-title":"Ultrasound and color doppler applications in chronic kidney disease","volume":"31","author":"Petrucci","year":"2018","journal-title":"J. Nephrol"},{"key":"2022123013015230300_kfac070-B22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"2022123013015230300_kfac070-B23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41581-018-0080-9","article-title":"Estimated GFR: Time for a critical appraisal","volume":"15","author":"Porrini","year":"2019","journal-title":"Nat. Rev. Nephrol"},{"key":"2022123013015230300_kfac070-B24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1523-1755.1998.00001.x","article-title":"The clinical spectrum of tubulointerstitial nephritis","volume":"54","author":"Rastegar","year":"1998","journal-title":"Kidney Int"},{"key":"2022123013015230300_kfac070-B25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.kint.2018.02.030","article-title":"Secondary IGA nephropathy","volume":"94","author":"Saha","year":"2018","journal-title":"Kidney Int"},{"key":"2022123013015230300_kfac070-B26","first-page":"407","article-title":"Hepatic glomerulosclerosis\u2013light microscopic study of autopsy cases","volume":"18","author":"Sakaguchi","year":"1968","journal-title":"Acta Pathol. Jpn"},{"key":"2022123013015230300_kfac070-B27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy\u2014Understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat. Rev. Nephrol"},{"key":"2022123013015230300_kfac070-B28","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022123013015230300_kfac070-B29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.21037\/atm.2019.01.18","article-title":"Systematic identification of key genes and pathways in clear cell renal cell carcinoma on bioinformatics analysis","volume":"7","author":"Tian","year":"2019","journal-title":"Ann. Transl. Med"},{"key":"2022123013015230300_kfac070-B30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00467-017-3715-3","article-title":"Liver involvement in kidney disease and vice versa","volume":"33","author":"Van Hoeve","year":"2018","journal-title":"Pediatr. Nephrol"},{"key":"2022123013015230300_kfac070-B31","first-page":"283","article-title":"Alcohol misuse and kidney injury: Epidemiological evidence and potential mechanisms","volume":"38","author":"Varga","year":"2017","journal-title":"Alcohol Res"},{"key":"2022123013015230300_kfac070-B32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","article-title":"Biomarkers of renal function, which and when?","volume":"438","author":"Wasung","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"2022123013015230300_kfac070-B33","doi-asserted-by":"crossref","first-page":"e925891","DOI":"10.12659\/AOT.925891","article-title":"Clinical relevance of kidney biopsy in patients qualified for liver transplantation and after this procedure in the model for end-stage liver disease (MELD) era: Where are we today?","volume":"25","author":"Wieliczko","year":"2020","journal-title":"Ann. Transplant"},{"key":"2022123013015230300_kfac070-B34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ajg.2017.122","article-title":"Acute kidney injury in cirrhosis: Baseline serum creatinine predicts patient outcomes","volume":"112","author":"Wong","year":"2017","journal-title":"Am. J. Gastroenterol"},{"key":"2022123013015230300_kfac070-B35","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/lt.25454","article-title":"Impact of chronic kidney disease on outcomes in cirrhosis","volume":"25","author":"Wong","year":"2019","journal-title":"Liver Transpl"},{"key":"2022123013015230300_kfac070-B36","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep4.1583","article-title":"Chronic kidney disease in patients with chronic liver disease: What is the price tag?","volume":"4","author":"Wong","year":"2020","journal-title":"Hepatol. Commun"},{"key":"2022123013015230300_kfac070-B37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2001.00474.x","article-title":"Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury","volume":"59","author":"Yamada","year":"2001","journal-title":"Kidney Int"},{"key":"2022123013015230300_kfac070-B38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ndt\/12.3.465","article-title":"Glomerular deposition of alpha 2-macroglobulin in glomerular diseases","volume":"12","author":"Yang","year":"1997","journal-title":"Nephrol. Dial. Transplant"},{"key":"2022123013015230300_kfac070-B39","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.4254\/wjh.v7.i17.2069","article-title":"Prediction of liver cirrhosis, using diagnostic imaging tools","volume":"7","author":"Yeom","year":"2015","journal-title":"World J. Hepatol"},{"key":"2022123013015230300_kfac070-B40","doi-asserted-by":"crossref","first-page":"20170959","DOI":"10.1259\/bjr.20170959","article-title":"Liver fat imaging\u2014A clinical overview of ultrasound, CT, and MR imaging","volume":"91","author":"Zhang","year":"2018","journal-title":"Br. J. Radiol"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfac070\/44887091\/kfac070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/189\/1\/62\/48448612\/kfac070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/189\/1\/62\/48448612\/kfac070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T13:02:27Z","timestamp":1672405347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/189\/1\/62\/6631245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,7,5]]},"published-print":{"date-parts":[[2022,8,25]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfac070","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,7,5]]}}}